Fact CheckerSign in

NCT07532187Completed

The Effects of Extracorporeal Shock Wave Therapy on Upper Extremity Spasticity and Function in Patients With Stroke

The Effects of Extracorporeal Shock Wave Therapy on Upper Extremity Spasticity and Function in Patients With Stroke: A Single-Arm Study

Source: ClinicalTrials.gov · Last updated 21 Oct 2026

Brief summary (registry, in English)

Spasticity is a common complication after stroke and can limit upper extremity motor control and activities of daily living. Radial extracorporeal shock wave therapy (rESWT) is a non-invasive treatment that has been investigated for post-stroke spasticity; however, treatment protocols vary widely across studies in the muscles treated, number of impulses, session frequency, energy parameters, and application sites. This prospective, single-center, single-arm study enrolled 30 adults with post-stroke hemiplegia and upper extremity spasticity to evaluate changes in clinical outcomes following an rESWT protocol with anatomically predefined target points. rESWT was applied to the biceps brachii, flexor carpi radialis, and flexor carpi ulnaris of the affected arm twice weekly for 4 weeks (8 sessions). Spasticity, upper extremity motor function, functional independence, quality of life, pain, depressive symptoms, and sensory findings were assessed at baseline, week 4, and week 12.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
8 Apr 2026
Start date
1 Jul 2025
Primary completion date
7 May 2026
Lead sponsor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Diseases
Stroke
NCT number
NCT07532187

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 1 Jul 2025 to the primary completion date, 7 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Systemic conditions contraindicating ESWT (active infection, malignancy, etc.)

Other

  • Impaired consciousness or severe cognitive deficit
  • Shoulder subluxation on the affected side
  • Skin integrity disruption at the application site

Who the study is looking for

  • Age 18 years or older
  • Diagnosis of hemiplegia following stroke
  • Minimum of 4 weeks elapsed since stroke onset
  • Modified Ashworth Scale (MAS) score ≥ 2 for elbow or wrist spasticity
  • Sufficient cognitive ability to follow simple commands
  • No botulinum toxin injection in the preceding 3 months
  • Willing to participate and signed informed consent form

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.